Financials
Income statement
Fiscal date | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
---|---|---|---|---|
Total reported revenue | 6.3B | 5.8B | 5.9B | 7.9B |
Cost of revenue | 4.6B | 4.4B | 4.5B | 5.0B |
Gross profit | 1.8B | 1.4B | 1.4B | 2.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 816M | 848M | 886M | 763M |
Other operating expenses | — | — | — | — |
Operating income | 934M | 542M | 560M | 2.2B |
Non operating interest income | ||||
Income | 12M | 7M | 16M | 19M |
Expense | 341M | 377M | 403M | 431M |
Other income expense | — | — | — | — |
Pretax income | 582M | -71M | 289M | 1.7B |
Tax provision | 17M | 7M | -14M | 8M |
Net income | 565M | -78M | 303M | 1.7B |
Basic EPS | 0.4 | -0.1 | 0.2 | 1.4 |
Diluted EPS | 0.4 | -0.1 | 0.2 | 1.3 |
Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.4B | 1.3B | 1.4B | 1.4B |
EBITDA | 927M | 1.2B | 1.4B | 2.2B |
Net income from continuing op. | — | -78M | 303M | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |